Clinical trialNCT06422884Active, not recruitingPhase 2Interventional

A Phase 2 Trial of ENV-101 in Patients With Lung Fibrosis (WHISTLE-PF Trial)

SponsorEndeavor Biomedicines, Inc.Enrollment213Idiopathic Pulmonary FibrosisProgressive Fibrosing Interstitial Lung Disease

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Lisa Lancaster, M.D.
Endeavor Biomedicines
Study DirectorKOL profile →
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

78 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Argentina

Research Site
Quilmes, Buenos Aires, Argentina
Research Site
Buenos Aires, Argentina
Research Site
Buenos Aires, Argentina
Research Site
Mendoza, Argentina
Research Site
Mendoza, Argentina

Australia

Research Site
Camperdown, New South Wales, Australia
Research Site
Macquarie Park, New South Wales, Australia
Research Site
Brisbane, Queensland, Australia
Research Site
South Brisbane, Queensland, Australia
Research Site
Box Hill, Victoria, Australia
Research Site
Nedlands, Western Australia, Australia

Austria

Research Site
Graz, Styria, Austria
Research Site
Vienna, Austria

Belgium

Research Site
Dinant, Namur, Belgium
Research Site
Brussels, Belgium
Research Site
Brussels, Belgium

Canada

Research Site
Edmonton, Alberta, Canada
Research Site
Vancouver, British Columbia, Canada
Research Site
Ajax, Ontario, Canada
Research Site
Montreal, Quebec, Canada
Research Site
Sherbrooke, Quebec, Canada
Research Site
Trois-Rivières, Quebec, Canada

France

Research Site
Angers, France
Research Site
Bordeaux, France
Research Site
Caen, France
Research Site
Dijon, France
Research Site
Montpellier, France
Research Site
Nantes, France
Research Site
Paris, France
Research Site
Paris, France
Research Site
Rennes, France
Research Site
Tours, France

Germany

Research Site
Giessen, Hesse, Germany
Research Site
Immenhausen, Hesse, Germany
Research Site
Hanover, Lower Saxony, Germany
Research Site
Essen, North Rhine-Westphalia, Germany
Research Site
Berlin, Germany
Research Site
Leipzig, Germany

Ireland

Research Site
Dublin, Leinster, Ireland
Research Site
Dublin, Leinster, Ireland

38 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 15 Nov 2024
Primary completion: 31 Oct 2026
Completion: 31 Oct 2026
Last update posted: 24 Feb 2026
Registered enrollment: 213
Registry id: NCT06422884

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.